GlobalData analyst Dr Andrew S Thompson expects the deal to prompt a "shuffle" in Thermo Fisher’s life sciences unit.

M health care spinoff Solventum is selling its purification business to Thermo Fisher Scientific for $4.1 billion in cash to ...

Solventum Corp., 3M’s medtech spinoff, has sold its purification and filtration business to Massachussetts-based Thermo ...

Thermo Fisher Scientific agreed to pay about $4.1 billion in cash to acquire Solventum’s purification and filtration business ...

Thermo Fisher Scientific confirmed that it agreed to purchase Solventum's purification and fitration unit for $4.1 billion in ...

Thermo Fisher Scientific said Tuesday it is buying Solventum’s purification and filtration business, confirming an earlier ...

The addition of Solventum’s business provides a strategic fit with Thermo Fisher and will create value for customers, according to Marc N. Casper, chairman, president, and CEO of Thermo Fisher.

Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, today announced that the company has entered into a ...

Shares in Solventum rallied after Thermo Fisher Scientific said it would buy the healthcare company's purification and filtration business for about $4.1 billion. Solventum was spun off from 3M last ...

Solventum shares are trading higher Tuesday after the company announced it will sell its purification and filtration business ...

Solventum’s Purification & Filtration business is highly complementary to Thermo Fisher’s bioproduction business. Solventum’s ...